{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:04:12Z","timestamp":1791320652577,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13045-015-0206-5","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T07:51:02Z","timestamp":1446709862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"8","author":[{"given":"Ilaria","family":"Iacobucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Ghelli Luserna","family":"Di Ror\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria Verga","family":"Falzacappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Derenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Papayannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Lonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Imbrogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pomella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Venturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Guadagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cattina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Abbenante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giuseppe","family":"Pelicci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"206_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","volume":"24","author":"V Conter","year":"2010","unstructured":"Conter V, Aric\u00f2 M, Basso G, Biondi A, Barisone E, Messina C, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:255\u201364.","journal-title":"Leukemia."},{"key":"206_CR2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"C-H Pui","year":"2008","unstructured":"Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030\u201343.","journal-title":"Lancet"},{"key":"206_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2012.01.001","volume":"26","author":"AV Moorman","year":"2012","unstructured":"Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev. 2012;26:123\u201335.","journal-title":"Blood Rev"},{"issue":"9","key":"206_CR4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(08)70229-8","volume":"9","author":"LC Bailey","year":"2008","unstructured":"Bailey LC, Lange BJ, Rheingold SR, Bunin NJ. Bone-marrow relapse in paediatric acute lymphoblastic leukaemia. Lancet Oncol. 2008;9(9):873\u201383.","journal-title":"Lancet Oncol"},{"issue":"6","key":"206_CR5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.hoc.2011.09.008","volume":"25","author":"AK Fielding","year":"2011","unstructured":"Fielding AK. Current therapeutic strategies in adult acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2011;25(6):1255\u201379.","journal-title":"Hematol Oncol Clin North Am"},{"key":"206_CR6","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1158\/1535-7163.MCT-07-2391","volume":"7","author":"A Blasina","year":"2008","unstructured":"Blasina A, Hallin J, Chen E, Arango ME, Kraynov E, Register J, et al. Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. Mol Cancer Ther. 2008;7:2394\u2013404.","journal-title":"Mol Cancer Ther"},{"key":"206_CR7","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1200\/JCO.2005.03.116","volume":"23","author":"J Kortmansky","year":"2005","unstructured":"Kortmansky J, Shah MA, Kaubisch A, Weyerbacher A, Yi S, Tong W, et al. Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors. J Clin Oncol. 2005;23:1875\u201384.","journal-title":"J Clin Oncol"},{"key":"206_CR8","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-08-0492","volume":"7","author":"SD Zabludoff","year":"2008","unstructured":"Zabludoff SD, Deng C, Grondine MR, Sheehy AM, Ashwell S, Caleb BL, et al. AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies. Mol Cancer Ther. 2008;7:2955\u201366.","journal-title":"Mol Cancer Ther"},{"key":"206_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1158\/1535-7163.MCT-06-0371","volume":"6","author":"S-K Sha","year":"2007","unstructured":"Sha S-K, Sato T, Kobayashi H, Ishigaki M, Yamamoto S, Sato H, et al. Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. Mol Cancer Ther. 2007;6:147\u201353.","journal-title":"Mol Cancer Ther"},{"key":"206_CR10","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1158\/1078-0432.CCR-08-3272","volume":"15","author":"C Zhang","year":"2009","unstructured":"Zhang C, Yan Z, Painter CL, Zhang Q, Chen E, Arango ME, et al. PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenografts. Clin Cancer Res. 2009;15:4630\u201340.","journal-title":"Clin Cancer Res"},{"key":"206_CR11","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1158\/0008-5472.CAN-04-2434","volume":"64","author":"RG Sylju\u00e5sen","year":"2004","unstructured":"Sylju\u00e5sen RG, S\u00f8rensen CS, Nylandsted J, Lukas C, Lukas J, Bartek J. Inhibition of Chk1 by CEP-3891 accelerates mitotic nuclear fragmentation in response to ionizing radiation. Cancer Res. 2004;64:9035\u201340.","journal-title":"Cancer Res"},{"key":"206_CR12","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1128\/MCB.25.9.3553-3562.2005","volume":"25","author":"RG Sylju\u00e5sen","year":"2005","unstructured":"Sylju\u00e5sen RG, S\u00f8rensen CS, Hansen LT, Fugger K, Lundin C, Johansson F, et al. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol. 2005;25:3553\u201362.","journal-title":"Mol Cell Biol"},{"key":"206_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1535-7163.MCT-08-0662","volume":"8","author":"LA Parsels","year":"2009","unstructured":"Parsels LA, Morgan MA, Tanska DM, Parsels JD, Palmer BD, Booth RJ, et al. Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. Mol Cancer Ther. 2009;8:45\u201354.","journal-title":"Mol Cancer Ther"},{"key":"206_CR14","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1158\/1078-0432.CCR-12-2442","volume":"18","author":"JE Karp","year":"2012","unstructured":"Karp JE, Thomas BM, Greer JM, Sorge C, Gore SD, Pratz KW, et al. Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias. Clin Cancer Res. 2012;18:6723\u201331.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"206_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ctrv.2012.10.007","volume":"39","author":"M Maugeri-Sacc\u00e0","year":"2013","unstructured":"Maugeri-Sacc\u00e0 M, Bartucci M, De Maria R. Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy. Cancer Treat Rev. 2013;39(5):525\u201333.","journal-title":"Cancer Treat Rev"},{"key":"206_CR16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1126\/science.288.5470.1425","volume":"288","author":"N Mailand","year":"2000","unstructured":"Mailand N, Falck J, Lukas C, Sylju\u00e2sen RG, Welcker M, Bartek J, et al. Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000;288:1425\u20139.","journal-title":"Science"},{"issue":"15","key":"206_CR17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4161\/cbt.8.15.9081","volume":"8","author":"K Kuntz","year":"2009","unstructured":"Kuntz K, O\u2019Connell MJ. The G2 DNA damage checkpoint: could this ancient regulator be the achilles heel of cancer? Cancer Biol Ther. 2009;8(15):1433\u20139.","journal-title":"Cancer Biol Ther"},{"key":"206_CR18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(03)00048-5","volume":"3","author":"CS S\u00f8rensen","year":"2003","unstructured":"S\u00f8rensen CS, Sylju\u00e5sen RG, Falck J, Schroeder T, R\u00f6nnstrand L, Khanna KK, et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell. 2003;3:247\u201358.","journal-title":"Cancer Cell"},{"key":"206_CR19","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1128\/MCB.23.21.7488-7497.2003","volume":"23","author":"M-S Chen","year":"2003","unstructured":"Chen M-S, Ryan CE, Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol. 2003;23:7488\u201397.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"206_CR20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003;3(5):421\u20139.","journal-title":"Cancer Cell"},{"key":"206_CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1078-0432.CCR-10-1215","volume":"17","author":"A Stolz","year":"2011","unstructured":"Stolz A, Ertych N, Bastians H. Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin Cancer Res. 2011;17:401\u20135.","journal-title":"Clin Cancer Res"},{"key":"206_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform1. Neoplasia. 2004;6:1\u20136.","journal-title":"Neoplasia"},{"key":"206_CR23","first-page":"3976","volume":"53","author":"SH Kaufmann","year":"1993","unstructured":"Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53:3976\u201385.","journal-title":"Cancer Res"},{"key":"206_CR24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.277.5331.1501","volume":"277","author":"CY Peng","year":"1997","unstructured":"Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 1997;277:1501\u20135.","journal-title":"Science"},{"key":"206_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4161\/cc.10.2.14543","volume":"10","author":"Y Xu","year":"2011","unstructured":"Xu Y, Price BD. Chromatin dynamics and the repair of DNA double strand breaks. Cell Cycle. 2011;10:261\u20137.","journal-title":"Cell Cycle"},{"key":"206_CR26","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M803111200","volume":"283","author":"K Matsuura","year":"2008","unstructured":"Matsuura K, Wakasugi M, Yamashita K, Matsunaga T. Cleavage-mediated activation of Chk1 during apoptosis. J Biol Chem. 2008;283:25485\u201391.","journal-title":"J Biol Chem"},{"issue":"8","key":"206_CR27","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-11-0949","volume":"11","author":"HJ Landau","year":"2012","unstructured":"Landau HJ, McNeely SC, Nair JS, Comenzo RL, Asai T, Friedman H, et al. The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cells. Mol Cancer Ther. 2012;11(8):1781\u20138.","journal-title":"Mol Cancer Ther"},{"key":"206_CR28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","volume":"18","author":"R Wisdom","year":"1999","unstructured":"Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 1999;18:188\u201397.","journal-title":"EMBO J"},{"key":"206_CR29","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006;24:2472\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0206-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:59:45Z","timestamp":1498244385000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jhoonline.org\/content\/8\/1\/125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1186\/s13045-015-0206-5","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]},"article-number":"125"}}